Renal Denervation Market Size is Estimated to be Valued $1.03 Billion by 2026: Grand View Research, Inc

Renal Denervation Market Size is Estimated to be Valued $1.03 Billion by 2026: Grand View Research, Inc

Grand View Research, Inc. – Market Research And Consulting
According to report published by Grand View Research, The global renal denervation market size was estimated at USD 41.7 million in 2017 and is anticipated to expand at a CAGR of 43.2% over the forecast period.

The global Renal Denervation Market size is expected to reach USD 1.03 billion by 2026, according to a new report by the Grand View Research, Inc. The market is estimated to register a CAGR of 43.2% during the forecast period. Growing incidences of hypertension, changing lifestyle, and enduring effect of renal denervation procedure are the key factors driving market.

Increasing cases of uncontrolled and drug-resistant hypertension are expected to fuel the demand for renal denervation. As per the data published in November 2016, by the Centre for Disease Control and Prevention (CDC), about 75 million people in U.S. have high blood pressure. High blood pressure increases the risk of stroke and heart disease, a leading cause of deaths in America. Complications of hypertension causes 9.4 million deaths each year. Furthermore, hypertension is responsible for at least 51% of deaths due to stroke and 45% of deaths due to heart disease.

The renal denervation market in developed economies, such as U.K., France, and Italy, is comparatively mature owing to the presence of key companies in these countries and high demand for such products. Europe commanded the largest share owing to the rise in number of drug-resistant hypertension cases and technological advancements.

On the other hand, developing countries of Asia and Latin America are expected to witness the fastest growth due to economic growth and increased consumer disposable income. Further, growing elderly population coupled with high prevalence of diabetes in these region sis anticipated to propel the region’s development.

Germany renal denervation market size, by technology, 2014 - 2026 (USD Million)

Request a Sample Copy of the Global Renal Denervation Market Research Report @

Further key findings from the report suggest:

  • Ultrasound based renal denervation segment is projected to register a remarkable CAGR of 43.5% over the forecast period as it overcomes the limitation of radiofrequency devices
  • Europe led the renal denervation market in 2017 due to high number of drug-resistant hypertension cases and initiatives, such as R&D, for the development of effective devices
  • Asian countries are estimated to witness the highest growth over the forecast period, due to increasing target population coupled with rising prevalence of diabetes
  • Developing countries of China and India are the major drivers of the regional market due to populations
  • Key companies in the market are Medtronic PLC; Cardiosonic, Inc.; Kona Medical, Inc.; Abbott Laboratories; Ablative Solutions, Inc.; Renal Dynamics; Mercator MedSystems, Inc.; ReCor Medical, Inc.; Boston Scientific Corp.; and Symple Surgical, Inc. 

Global renal denervation market share, by region, 2017 (%)

Have Any Query? Ask Our Experts@

Grand View Research has segmented the global renal denervation market on the basis of technology and region:

Renal Denervation Technology Outlook (Revenue, USD Million, 2014 – 2026)

  • Radiofrequency Based Renal Denervation
  • Ultrasound Based Renal Denervation
  • Micro-Infusion Based Renal Denervation

Renal Denervation Regional Outlook (Revenue, USD Million, 2014 – 2026)

  • North America
    • U.S.
    • Canada
    • Europe
      • U.K.
      • Germany
    • Asia Pacific
      • Japan
      • China
    • Latin America
      • Brazil
      • Mexico
    • Middle East & Africa
      • South Africa
      • Saudi Arabia

Browse Related Category @

Nephrostomy Devices Market: Increasing cases of kidney stone disorder, rise in demand for minimally invasive surgical procedures, and increased awareness about the product are a few factors driving the market.

Urolithiasis Management Devices Market: Increasing prevalence of urinary stones and its higher recurrence rate will drive the growth of the urolithiasis management devices market over the forecast period

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States